Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Pre‐symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post‐birth: 14‐month safety and developmental outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s2352‐4642(22)00342‐x
10.1016/s2352‐4642(22)00342‐x · External reference
10.1016/j.lanepe.2024.101092
10.1016/j.lanepe.2024.101092 · External reference
10.3389/fneur.2024.1308296
10.3389/fneur.2024.1308296 · External reference
10.3760/cma.j.cn112137‐20230310‐00372
10.3760/cma.j.cn112137‐20230310‐00372 · External reference
10.3969/j.issn.1673‐5501.2024.02.003
10.3969/j.issn.1673‐5501.2024.02.003 · External reference
10.1007/s40261‐023‐01320‐4
10.1007/s40261‐023‐01320‐4 · External reference
